CEP135 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.178300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.310200E-01
Normal-vs-Stage2
6.549500E-02
Normal-vs-Stage3
1.405840E-01
Normal-vs-Stage4
7.020000E-01
Stage1-vs-Stage2
4.909400E-01
Stage1-vs-Stage3
4.897600E-01
Stage1-vs-Stage4
1.895990E-01
Stage2-vs-Stage3
2.544600E-01
Stage2-vs-Stage4
2.315800E-01
Stage3-vs-Stage4
1.635950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.624100E-02
Normal-vs-AfricanAmerican
3.727000E-01
Normal-vs-Asian
3.148200E-01
Caucasian-vs-AfricanAmerican
7.789400E-01
Caucasian-vs-Asian
3.094200E-01
AfricanAmerican-vs-Asian
5.319600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.227600E-02
Normal-vs-Female
8.674200E-02
Male-vs-Female
4.487400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.073400E-01
Normal-vs-Age(41-60Yrs)
4.513400E-01
Normal-vs-Age(61-80Yrs)
6.832500E-02
Normal-vs-Age(81-100Yrs)
3.242200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.468800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.332000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.304400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.749800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.366000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.763400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.375000E-01
Normal-vs-Daily Drinker
3.114800E-01
Normal-vs-Weekly Drinker
1.630150E-01
Normal-vs-Occasional Drinker
3.932600E-01
Normal-vs-Social Drinker
1.604800E-01
Non Drinker-vs-Daily Drinker
6.221600E-01
Non Drinker-vs-Weekly Drinker
4.987600E-01
Non Drinker-vs-Occasional Drinker
4.131600E-01
Non Drinker-vs-Social Drinker
2.827000E-01
Daily Drinker-vs-Weekly Drinker
3.825600E-01
Daily Drinker-vs-Occasional Drinker
2.033800E-01
Daily Drinker-vs-Social Drinker
1.616810E-01
Weekly Drinker-vs-Occasional Drinker
9.648000E-01
Weekly Drinker-vs-Social Drinker
8.109600E-01
Occasional Drinker-vs-Social Drinker
7.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.740000E-01
Normal-vs-Grade 2
7.962600E-01
Normal-vs-Grade 3
8.473000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.261000E-01
Grade 1-vs-Grade 3
2.603200E-01
Grade 1-vs-Grade 4
7.740000E-01
Grade 2-vs-Grade 3
2.871800E-01
Grade 2-vs-Grade 4
7.962600E-01
Grade 3-vs-Grade 4
8.473000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.413000E-01
Normal-vs-NonDiabetic
3.678600E-01
Diabetic-vs-NonDiabetic
5.097200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.096800E-01
Normal-vs-NoPancreatitis
3.673200E-01
Pancreatitis-vs-NoPancreatitis
1.601040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.050000E-02
Normal-vs-N1
6.308100E-02
N0-vs-N1
9.781400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.808200E-01
Normal-vs-TP53-NonMutant
3.894200E-01
TP53-Mutant-vs-TP53-NonMutant
1.518020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
